Overview
The goal of this randomised clinical trial is to investigate the effectiveness of an innovative therapeutic exercise program emphasizing in dual-task exercises in people with amnestic Mild Cognitive Impairment. The main questions it aims to answer are:
Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition?
Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise).
Participants will:
- Perform the exercise program twice a week for three months.
- Will be assessed before and after the intervention.
- Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.
Eligibility
Inclusion Criteria:
- individuals \> 50 years old
- people with confirmed cognitive impairment, as evidenced by values within normal limits on the Montreal Cognitive Assessment test (MOCA ) \>20
- stable medication in the last month
- independent walking
Exclusion Criteria:
- people with dementia
- people suffering from chronic mental illness (e.g. schizophrenia, bipolar disorder)
- people suffering from a neurological disorder or injuries (e.g. multiple sclerosis, Parkinson's, traumatic brain injury)
- people with clinical depression (as determined by the Neuropsychiatric Inventory (NPI) assessment and medical diagnosis)
- people who have had recent surgery
- people with insufficient knowledge of the Greek language